Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Dejun Liu

Matched on ORCID iD 0000-0002-8091-0375; OpenAlex author ID A5036714100. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 4 papers · 2026: 1 paper

Papers 12

  1. A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neuron.2026.03.039↗
  2. Identification of Tumor-Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcin… Co-author DOI 10.1002/advs.202414982↗
  3. Vitamin K-dependent gamma-carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosin… Co-author DOI 10.1002/ctm2.70191↗
  4. Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer. Co-author DOI 10.1002/ctm2.70424↗
  5. ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner. Co-author DOI 10.1038/s41417-024-00864-7↗
  6. AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression. Co-author DOI 10.1016/j.canlet.2024.217130↗
  7. A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. Last author DOI 10.1016/j.celrep.2024.114633↗
  8. A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-021-02159-9↗
  9. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1. Co-author DOI 10.1038/s41419-019-2072-5↗
  10. Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patients. Co-author DOI 10.3892/ol.2018.8452↗
  11. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.6772↗
  12. Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma. Co-author PMID 27648368↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongwei Sun · 8 shared papers, 2016–2025 · strength 0.93
  2. Shu‐Heng Jiang · 5 shared papers, 2016–2026 · strength 0.80
  3. Linli Yao · 4 shared papers, 2022–2026 · strength 0.70
  4. Li-Peng Hu · 4 shared papers, 2022–2026 · strength 0.67
  5. Yan‐Miao Huo · 6 shared papers, 2016–2024 · strength 0.60
  6. Zong‐Hao Duan · 3 shared papers, 2024–2025 · strength 0.56
  7. Xueli Zhang · 3 shared papers, 2022–2026 · strength 0.53
  8. Xiaomei Yang · 3 shared papers, 2022–2026 · strength 0.53
  9. Zhigang Zhang · 4 shared papers, 2016–2025 · strength 0.45
  10. Minwei Yang · 5 shared papers, 2016–2024 · strength 0.43
  11. Yu-Heng Zhu · 2 shared papers, 2024–2026 · strength 0.38
  12. Hong‐Fei Yao · 2 shared papers, 2024–2026 · strength 0.38
  13. Qin-Yuan Jia · 2 shared papers, 2024 · strength 0.35
  14. Jia-Hao Zheng · 2 shared papers, 2024 · strength 0.35
  15. Yifan Yin · 2 shared papers, 2024 · strength 0.35
  16. Qing Li · 2 shared papers, 2022–2024 · strength 0.30
  17. Junfeng Zhang · 2 shared papers, 2019–2026 · strength 0.27
  18. Jian‐Yu Yang · 4 shared papers, 2016–2019 · strength 0.25
  19. Xueliang Fu · 4 shared papers, 2016–2019 · strength 0.25
  20. Rong Hua · 4 shared papers, 2016–2019 · strength 0.25
  21. Jichun Gu · 1 shared paper, 2025 · strength 0.25
  22. Rong-Kun Li · 1 shared paper, 2025 · strength 0.25
  23. H Li · 1 shared paper, 2025 · strength 0.25
  24. Chunhua Dai · 1 shared paper, 2025 · strength 0.25
  25. Qian Ji · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.